RevMAb
Recombinant monoclonal antibodies
RevMAb Biosciences USA is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.
Product Range:
- anti-Histone antibodies / Histone modifications
- Mutation specific antibodies against Histone mutations and other point mutations of other proteins
- Mutations specific antibodies for Immunohistochemistry / IHC
- Antibodies for immunohistochemistry
- Pan-Protein modification antibodies
- Secondary antibodies
- Matched pair antibodies for the detection of human Ig classes and IgG Subclasses
Reliance Biosciences
LipoMin™ EV purification
Reed Biotech
Biological immune protein research
EnkiLife
Cell biology
Sanyou Bio
Innovative Biologics for Research and Development
Apop Biosciences
Powering cell stress detection